Radiation Oncology/Therapy: Page 10

French university hospital picks ViewRay rad therapy system

By AuntMinnieEurope.com staff writers

ViewRay said Centre Oscar Lambret has become the first university hospital in Lille, France, to acquire its MRIdian MRI-guided radiation therapy system.

July 28, 2022

ITM selects Marx as chief business officer

By AuntMinnieEurope.com staff writers

German radiopharmaceutical developer ITM Isotope Technologies Munich has named Sebastian Marx, PhD, as its chief business officer.

July 21, 2022

NorthStar inks Ac-225 supply deal with Clovis

By AuntMinnieEurope.com staff writers

NorthStar Medical Radioisotopes has signed a long-term supply agreement with Clovis Oncology for NorthStar's actinium-225 (Ac-225) therapeutic radioisotope.

July 21, 2022

Clarity completes recruitment for prostate cancer trial

By AuntMinnieEurope.com staff writers

Australian radiopharmaceutical developer Clarity Pharmaceuticals has completed recruitment for a PET study of its theranostic agent with copper-based radioisotopes for treating patients with prostate cancer.

July 19, 2022

ECR: Should patient shielding stay or should it go?

By Will Morton

European experts are gradually reaching a consensus that radiation shielding is no longer needed for some imaging exams, yet this notion is proving a hard pill to swallow at some hospitals. With that in mind, a panel discussion held on Friday at ECR 2022 addressed the pros and cons of the issue.

July 15, 2022

Accuray highlights data presented at ISRS 2022

By AuntMinnieEurope.com staff writers

Radiation therapy developer Accuray is highlighting research being presented at the International Stereotactic Radiosurgery Society (ISRS) meeting in Milan, Italy, that the company says demonstrates the value of its CyberKnife system for treating neurological indications.

July 12, 2022

Prostate cancer patients lack sexual and emotional support

By AuntMinnieEurope.com staff writers

Many patients undergoing treatment for prostate cancer have no support for sexual and emotional issues, according to survey results presented at the UK Imaging & Oncology Conference in Liverpool.

July 7, 2022

PET/CT compares well with MRI for prostate cancer detection

By Kate Madden Yee

Prostate-specific membrane antigen-PET/CT imaging is comparable to MRI for detecting clinically significant prostate cancer. But MRI is still the more accurate modality for determining the grade of disease, according to the results of a new study.

July 6, 2022

IBA forms ConformalFlash alliance

By AuntMinnieEurope.com staff writers

Proton therapy developer Ion Beam Applications (IBA) has launched the ConformalFlash Alliance, a new collaboration between companies and academia to facilitate clinical adoption of the firm's ConformalFlash technology.

July 4, 2022

Spago Nanomedical completes fundraising round

By AuntMinnieEurope.com staff writers

Spago Nanomedical recently completed its rights issue fundraising round in a rights issue, saying it will raise about 58.4 million Swedish krona (5.4 million euros) before deduction of costs.

June 30, 2022

Sectra announces AI contract in U.K.

By AuntMinnieEurope.com staff writers

Enterprise imaging and digital pathology vendor Sectra has secured a deal with Portsmouth Hospitals University NHS Trust for the health network to test the company's Sectra Amplifier Service.

June 30, 2022

RaySearch releases RayCare update

By AuntMinnieEurope.com staff writers

Radiation therapy software developer RaySearch Laboratories has launched RayCare 6A, the latest version of its oncology information system for collecting and managing data during various stages of cancer care.

June 23, 2022

Previous Page

Page 10 of 127

Next Page